Connect with us

Published

on

The proliferation of weight-loss drugs like Ozempic is having an unintended side-effect on snack makers — a reduction in sales, according to a report.

Walmart said customers who have been taking the popular meds to slim down are cutting back on high-fat and salty treats because the weight-loss drugs help to suppress appetites.

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” John Furner, the CEO of Walmarts US operation, told Bloomberg.

Walmart, which sells weight-loss drugs at its pharmacies, is able to study changes in sales patterns using anonymized data on shopper populations, according to the outlet.

With those data sets, the Bentonville, Ark.-based can see how many customers are on diabetes-turned-weight-loss drugs like Ozempic, Wegovy, and Mounjaro and compare their shopping habits to those not taking the medications.

Furner said people on weight-loss drugs are purchasing “less units, slightly less calories,” but said that it’s too soon to conclude what effect the meds are having on Walmart’s overall sales.

Representatives for Walmart did not immediately respond to The Post’s request for comment.

One woman who takes Mounjaro said the reduction in appetite has cut her grocery bill by as much as 20%.

I still have a fully stocked kitchen, theres chips and pretzels in there. I dont find it tempting, Carolyn MacBain-Waldo told the Wall Street Journal.

Another Mounjaro user said she doesnt think about food all the time anymore and eats far fewer snacks.

The other day I had a single jelly bean, which is unheard of for me, Karyn Carlton, 47, told The Journal, adding that she also recently ordered a kids meal from a fast-food restaurant and felt satiated.

The drug, which stimulates the body to produce insulin and lowers blood sugar, has historically been used to treat Type 2 diabetes but was popularized after patients discovered their slimming effects, and particularly exploded when it was revealed celebrities like Khloe Kardashian and Chelsea Handler admitted to using it.

Their use has filtered to middle America and is only expected to grow, despite disturbing case studies where the medications paralyzed some users’ stomachs and even burned off one woman’s genitals.

Morgan Stanley estimated that 7% of the US population, or 24 million people, will be taking hunger-suppressing weight-loss drugs by 2035 — cutting their daily calorie consumption by as much as 30%, according to the firm, which surveyed over 300 patients.

For a person on an FDA-recommended 2,000-calorie daily diet, that could mean eliminating a one-ounce bag of salted potato chips, a bottle of soda, and more each day.

“The food, beverage, and restaurant industries could see softer demand, particularly for unhealthier foods and high-fat, sweet, and salty options, said Morgan Stanleys tobacco and packaged food analyst Pamela Kaufman.

Kaufman said major food companies like Conagra Brands, Mondelez, and Campbell Soup could see a 3% hit to their bottom lines by 2035.

Kellogg’s Brands, which is behind popular snack foods like Cheez-Its and Pringles, has reportedly been studying the potential impact popular weight-loss drugs could have on consumer behaviors.

“Like everything that potentially impacts our business, well look at it, study it and, if necessary, mitigate,” Kellogg’s chief Steve Cahillane told Bloomberg.

Cahillane called it “very, very early days” for the drugs, but said the company, which also makes Rice Krispie Treats, was “by no means complacent,” suggesting Kellogg’s would make changes to its products if overweight Americans on weight-loss medications continued limiting their calorie intake.

The Post has sought comment from Kellogg’s.

Despite being “early days,” US sales for GLP-1-containing drugs have experienced a whopping 300% increase in prescription volume from 2020 to 2022, according to Trilliant Health.

Of those prescriptions, Ozempic was the most-prescribed GLP-1, and national spending on semaglutide — the peptide name for Ozempic and Wegovy — now exceeds $10 billion, Trilliant Health said.

Continue Reading

Environment

Trump nominates a Tesla critic to lead NHTSA

Published

on

By

Trump nominates a Tesla critic to lead NHTSA

President Trump has nominated Jonathan Morrison to lead the National Highway Traffic Safety Administration (NHTSA). Morrison has previously criticized and tussled with Tesla in his previous role at NHTSA.

Morrison is now Trump’s nominee to head the National Highway Traffic Safety Administration, which is in charge of regulating the auto industry in the US.

The attorney was the agency’s Chief Counsel during Trump’s first term, and he had a few disputes with Tesla during that time.

In September 2018, the US National Highway Traffic Safety Administration (NHTSA) released its Tesla Model 3 crash test results, and the EV got five-star safety ratings in every category.

Advertisement – scroll for more content

Tesla interpreted the data from the test and claimed that Model 3 achieved “the lowest probability of injury of any vehicle ever tested by NHTSA“.

Morrison sent Tesla a cease-and-desist letter over the claim, arguing that it was misleading.

The lawyers also subpoenaed Tesla to get data about a specific crash in 2019.

Next week, Morrison is expected to have his confirmation hearing in the Senate and could take up his role shortly after.

The nomination is significant in the context of the current feud between Tesla CEO Elon Musk and President Trump.

Musk has been criticizing Trump and his allies over their recently passed budget and tax bill, which is expected to significantly increase the federal government’s debt and eliminate virtually all subsidies to electric vehicles and renewable energy, potentially harming Tesla.

Trump has warned Musk that he could go directly after his companies and NHTSA would be the top vehicle for that when it comes to Tesla.

The agency had already launched several investigations into Tesla over the years, with the largest one examining Tesla’s Full Self-Driving program and several fatal crashes related to the ADAS system.

Electrek’s Take

Most NHTSA probes into Tesla have resulted in slaps on the wrist at best, but this FSD probe involves several fatal crashes, and even though it started under the Biden administration, it could potentially ramp up under Trump, especially amid his feud with Musk.

On the one hand, it’s disheartening to see the US reach this point, where feuds between billionaires and elected officials are settled through regulatory agencies. Still, at the same time, Musk did buy the election for Trump, so he created this situation in the first place, and there are serious concerns about how safe FSD is.

At the very least, I would hope that NHTSA will start to force Tesla to release all its FSD crash and disengagement data.

FTC: We use income earning auto affiliate links. More.

Continue Reading

Environment

A 25 mph ambulance? The GEM microcar is now an emergency responder

Published

on

By

A 25 mph ambulance? The GEM microcar is now an emergency responder

You might remember the GEM as a quirky little electric microcar that’s been cruising through campuses, resorts, and planned communities for years. But now, it’s taking on a more serious job – saving lives. Waev Inc., the maker behind the long-running GEM electric vehicle line, has just unveiled the GEM Ambulance, a purpose-built, all-electric, street-legal low-speed vehicle (LSV) designed specifically for emergency medical services.

While it might not replace a full-size ambulance on high-speed highways, this new electric responder is tailor-made for the dense environments where conventional ambulances often struggle: college campuses, sporting events, entertainment venues, airports, and more. With a top speed of 25 mph, it’s built for maneuverability, safety, and zero-emission performance in pedestrian-heavy areas.

“The GEM Ambulance fills a critical gap in medical response – delivering the ideal balance of agility and safety EMS teams need in crowded settings,” said Byron Dudley, Vice President at Waev Inc.

The new GEM Ambulance is built on the same proven electric platform that has powered GEM vehicles for over 25 years. It’s a highly refined LSV that combines practical engineering with professional-grade EMS functionality. In partnership with emergency equipment supplier QTAC, Waev integrated a skid-mounted EMS system that includes secure patient transport, attendant seating, optional oxygen and IV mounts, and rugged PolyTough™ construction designed to handle demanding conditions.

Advertisement – scroll for more content

Unlike golf carts or UTV-based setups that have been DIYed into emergency vehicles, the GEM Ambulance offers a more stable, comfortable, and professional platform. The EMS skid is positioned between the wheels for better weight distribution, and the vehicle’s low deck height and rear step-up provide easy access for patients and personnel alike.

The GEM Ambulance doesn’t skimp on emergency essentials either. It’s equipped with a 360-degree red emergency lighting system, an SAE Class 1-compliant siren with multiple sound patterns, a public address system, turn signals, LED headlights and taillights, and even a pedestrian noise emitter for quiet zones. A backup camera and full 360° sightlines give drivers added confidence when navigating tight environments.

And since it’s 100% electric, there’s no tailpipe emissions to worry about when operating indoors or in crowded spaces. Maintenance is minimal thanks to GEM’s maintenance-free batteries, regenerative braking, and corrosion-resistant aluminum frame. There’s even a seven-year warranty on the lithium-ion battery option.

The biggest surprise might be the price. According to Waev, the GEM Ambulance can cost up to 80% less than a traditional ambulance and 50% less than electric trucks or UTV-based alternatives. Plus, with operating costs of just $0.03 per mile, it promises long-term savings with no fuel, no fluids, and no downtime from engine servicing.

With applications ranging from college campuses and amusement parks to military installations and warehouse sites, the GEM Ambulance could be a game-changer for localized EMS response. It’s available now through GEM’s nationwide dealer network and can also be purchased through government contracts like Sourcewell, Texas BuyBoard, and GSA procurement channels.

FTC: We use income earning auto affiliate links. More.

Continue Reading

Technology

Microsoft Outlook hit with hours-long outage

Published

on

By

Microsoft Outlook hit with hours-long outage

Omar Marques | Lightrocket | Getty Images

Microsoft‘s Outlook email service malfunctioned for several hours Wednesday and Thursday, prompting some people to post on social media about the inability to reach their virtual mailboxes.

The issue began at 6:20 p.m. Eastern time on Wednesday, according to a dashboard the software company maintains. It affected Outlook.com as well as Outlook mobile apps and desktop programs.

At 12:21 ET the Microsoft 365 Status account posted that it was rolling out a fix.

“Our configuration changes have effectively resolved impact in targeted infrastructure. We’re now deploying the changes worldwide to resolve impact for all users,” Microsoft said in an X post on Thursday afternoon.

The company’s status page said “most impacted users will experience relief within the next two hours,” and that it was continuing to monitor the service.

Read more CNBC tech news

On social media, some people reported that Outlook was functioning properly after hours of users posting about problems.

Some posts included screenshots of Outlook that said “something went wrong.” 

With hundreds of millions of active users, Outlook is important, although Apple and Google‘s email clients are more popular, according to data from analytics company Litmus

Continue Reading

Trending